Filing Details
- Accession Number:
- 0001232524-18-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-05 18:52:06
- Reporting Period:
- 2018-06-01
- Accepted Time:
- 2018-06-05 18:52:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601583 | P. Matthew Young | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-06-01 | 5,000 | $58.72 | 41,268 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-06-01 | 5,000 | $170.04 | 36,268 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non-Qualified Stock Option (right to buy) | Disposition | 2018-06-01 | 5,000 | $0.00 | 5,000 | $58.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,192 | 2023-05-02 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Includes 65 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2018.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $170.0000 to $170.3100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- This non-qualified stock option is part of an option award granted on May 3, 2013. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of April 22, 2013, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of April 22, 2017.
Billionaire Hedge Funds
